Primary allogeneic stem cell transplantation versus best available drug treatment in chronic myeloid leukemia by Prof. R. Hehlmann given during the 12th Congress of the European Hematology Association powered by - MULTIWEBCAST

12th Congress of the European Hematology Association

WELCOME MESSAGE

LIST OF PRESENTATIONS

OTHER WEBCASTS

Webcasted Presentation

BROWSE:

Prof. R. Hehlmann

Mannheim

Germany

Biography

Primary allogeneic stem cell transplantation versus best available drug treatment in chronic myeloid leukemia

English

2007-06-09

Topic: Chronic Myeloid Leukemia

PRESENTATION

26 slide(s)

Extra Features Available

SLIDE LIBRARY

Disclosure

There was no company support of the study.

Disclaimer ^{AMENDED ON January 29, 2009} | Close This Window | Technical Support

USER ACKNOWLEDGES AND AGREES THAT ALL DECISIONS MADE WITH THE ASSISTANCE OR USE OF THE SOFTWARE AND/OR THE WEBSITE AND/OR BASED ON CONTENT FOUND HEREIN WILL BE EXCLUSIVELY THE RESPONSIBILITY OF THE USER.

Search’n Build™ Search presentations by keyword and instantly build your own highlight of the conference!

Search’n Build™
Search presentations by keyword and instantly build your own highlight of the conference!